The resumption of trading for Corbus Pharmaceuticals (CRBP) typically leads to a temporary increase in volatility due to market participants reacting to the halt and subsequent return to trading. However, without additional context on the reasons for the trading halt, it is difficult to predict the direction of the stock price movement. Therefore, the score is neutral.